Is a brushite renal stone adherent to a papillary plug painful?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brushite Kidney Stones Attached to Papillary Plugs: Pain Considerations

Yes, brushite kidney stones attached to papillary ductal plugs are typically painful, as they cause obstruction, inflammation, and tissue injury at the level of the collecting ducts and surrounding renal parenchyma.

Mechanism of Pain in Brushite Stones with Ductal Plugging

Brushite stones demonstrate a unique attachment mechanism compared to calcium oxalate stones—they grow attached to apatite ductal plugs rather than Randall's plaque 1. This ductal plugging creates several pain-generating processes:

  • Terminal collecting duct obstruction occurs when apatite crystals plug scattered collecting ducts, causing direct tubular injury and cell death 2
  • Intranephronal obstruction from crystallization obstructs and destroys terminal collecting duct segments, damaging nephrons and producing localized pressure and inflammation 2
  • Severe interstitial inflammation and fibrosis surrounds the plugged ducts, with marked inflammatory cell infiltration that generates pain signals 2
  • Increased neutrophil infiltration and NETosis (neutrophil extracellular trap formation) is significantly elevated in brushite stone formers compared to calcium oxalate formers, contributing to inflammatory pain 3

Clinical Presentation and Pain Characteristics

Brushite stone formers present with distinct clinical features that contribute to their pain profile:

  • Large stone burden is common, with mean stone area of 29.2 mm² (range 2-130 mm²), and bilateral stones present in 34.1% of patients 4
  • Recurrent stone events occur in 37.8% of patients at a mean of 33 months from treatment, leading to repeated episodes of pain 4
  • Prior shock wave lithotripsy has been performed in nearly 80% of brushite stone formers, which may contribute to ongoing renal injury and pain 4
  • Moderate to severe cortical fibrosis, tubular atrophy, and glomerular pathology develop secondary to collecting duct plugging, creating chronic pain potential 2

Distinguishing Features from Other Stone Types

The pain mechanism in brushite stones differs fundamentally from calcium oxalate stones:

  • No Randall's plaque association was found in any brushite-containing stone examined by micro-CT, indicating a completely different attachment mechanism 1
  • Ductal plug overgrowth represents the primary mechanism of early stone growth and retention in brushite disease 1
  • Combined pathology includes both interstitial plaque (like calcium oxalate formers) and collecting duct apatite plugs (like intestinal bypass patients), creating more extensive tissue damage 2
  • Increased tubule plugging is observed in brushite formers compared to calcium oxalate formers, correlating with inflammatory signatures 3

Management Implications for Pain Control

When managing pain in brushite stone formers with ductal plugging:

  • NSAIDs (diclofenac, ibuprofen, metamizole) should be first-line analgesics for acute renal colic, using the lowest effective dose 5
  • Opioids serve as second-choice analgesics when NSAIDs are contraindicated or insufficient, with agents other than pethidine preferred (hydromorphone, pentazocine, tramadol) 5
  • Urgent decompression via percutaneous nephrostomy or ureteral stenting is mandatory within hours if sepsis or anuria is present 6
  • Ureteroscopy is first-line definitive treatment with 90% stone-free rate in a single procedure, though brushite stones are resistant to shock wave lithotripsy 6, 4

Metabolic Abnormalities Contributing to Pain

All brushite stone formers demonstrate underlying metabolic abnormalities that perpetuate stone formation and pain:

  • Hypercalciuria (>250 mg daily for women, >275 mg daily for men) occurs in 80.9% of patients 4
  • Elevated urine pH (>6.2) is present in 61.7% of patients 4
  • Distal renal tubular acidosis (dRTA) was noted in 50% of brushite stone formers, though relative supersaturation of brushite did not differ between those with and without dRTA 7
  • Low urine volume (<2 L daily) affects 57.4% of patients 4

Critical Pitfall to Avoid

Do not assume brushite stones behave like typical calcium oxalate stones—they require ballistic fragmentation rather than ultrasonic or shock wave lithotripsy due to their resistance to these modalities 8. Attempting shock wave lithotripsy may worsen renal injury and pain while failing to adequately fragment the stone 8.

References

Research

Profile of the brushite stone former.

The Journal of urology, 2010

Guideline

Pain Control Medications for Ureteral Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Unilateral Obstructing Urolithiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.